Skip to main content
Premium Trial:

Request an Annual Quote

Strand Genomics to Add ADME-Predict Models to Bio-Rad ADME/Tox assessment Platform

NEW YORK, Aug. 13 (GenomeWeb News) - Strand Genomics and Bio-Rad are collaborating to integrate Strand's predictive human pharmacokinetic models into Bio-Rad's in silico ADME/Tox assessment platform, KnowItAll, the companies said earlier this week.

 

Strand, of Bangalore, India, has developed ADME-Predict models to make predictions of pharmacokinetic parameters including bioavailability, volume of distribution, plasma half-life, and protein binding.

 

Bio-Rad said it added Strand's predictors in order to maintain "the most comprehensive ADME/Tox prediction portfolio" for drug discovery.

 

The parties did not disclose the financial terms of the agreement.

 

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.